These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21827410)

  • 1. In vitro modeling of the blood-brain barrier: simplicity versus complexity.
    Ogunshola OO
    Curr Pharm Des; 2011; 17(26):2755-61. PubMed ID: 21827410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Blood-Brain Barrier on a Chip: Featuring Unique Multicellular Cooperation in Pathophysiology.
    Ahn SI; Kim Y
    Trends Biotechnol; 2021 Aug; 39(8):749-752. PubMed ID: 33602608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What human blood-brain barrier models can tell us about BBB function and drug discovery?
    Ferreira L
    Expert Opin Drug Discov; 2019 Nov; 14(11):1113-1123. PubMed ID: 31385723
    [No Abstract]   [Full Text] [Related]  

  • 5. Imaging blood-brain barrier dysfunction in animal disease models.
    Wunder A; Schoknecht K; Stanimirovic DB; Prager O; Chassidim Y
    Epilepsia; 2012 Nov; 53 Suppl 6():14-21. PubMed ID: 23134491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines.
    Pérez-López A; Torres-Suárez AI; Martín-Sabroso C; Aparicio-Blanco J
    Adv Drug Deliv Rev; 2023 May; 196():114816. PubMed ID: 37003488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview and introduction: the blood-brain barrier in health and disease.
    Abbott NJ; Friedman A
    Epilepsia; 2012 Nov; 53 Suppl 6(0 6):1-6. PubMed ID: 23134489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier.
    Josserand V; Pélerin H; de Bruin B; Jego B; Kuhnast B; Hinnen F; Ducongé F; Boisgard R; Beuvon F; Chassoux F; Daumas-Duport C; Ezan E; Dollé F; Mabondzo A; Tavitian B
    J Pharmacol Exp Ther; 2006 Jan; 316(1):79-86. PubMed ID: 16210395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
    Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
    Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Status of
    Shah B; Dong X
    Curr Drug Deliv; 2022; 19(10):1034-1046. PubMed ID: 35240972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cerebrovascular modeling in the 21st century: current and prospective technologies.
    Palmiotti CA; Prasad S; Naik P; Abul KM; Sajja RK; Achyuta AH; Cucullo L
    Pharm Res; 2014 Dec; 31(12):3229-50. PubMed ID: 25098812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the Permeability of the Blood-brain Barrier in Three Different Models in vivo.
    Liu WY; Wang ZB; Wang Y; Tong LC; Li Y; Wei X; Luan P; Li L
    CNS Neurosci Ther; 2015 Jul; 21(7):568-74. PubMed ID: 25982054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Blood-Brain Barrier (BBB) and in vitro BBB Models].
    Takeshita Y; Kanda T
    Brain Nerve; 2015 Aug; 67(8):1035-42. PubMed ID: 26241364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro models of the blood-brain barrier.
    Czupalla CJ; Liebner S; Devraj K
    Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of the blood-brain barrier: animal models and methods.
    Hawkins BT; Egleton RD
    Curr Top Dev Biol; 2008; 80():277-309. PubMed ID: 17950377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation.
    Megard I; Garrigues A; Orlowski S; Jorajuria S; Clayette P; Ezan E; Mabondzo A
    Brain Res; 2002 Feb; 927(2):153-67. PubMed ID: 11821009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study.
    van Vliet EA; Otte WM; Gorter JA; Dijkhuizen RM; Wadman WJ
    Neurobiol Dis; 2014 Mar; 63():74-84. PubMed ID: 24321435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical component to establish in vitro BBB model: Pericyte.
    Lai CH; Kuo KH
    Brain Res Brain Res Rev; 2005 Dec; 50(2):258-65. PubMed ID: 16199092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier models: Rationale for selection.
    Hanafy AS; Dietrich D; Fricker G; Lamprecht A
    Adv Drug Deliv Rev; 2021 Sep; 176():113859. PubMed ID: 34246710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain.
    Modarres HP; Janmaleki M; Novin M; Saliba J; El-Hajj F; RezayatiCharan M; Seyfoori A; Sadabadi H; Vandal M; Nguyen MD; Hasan A; Sanati-Nezhad A
    J Control Release; 2018 Mar; 273():108-130. PubMed ID: 29378233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.